These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3250227)

  • 21. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.
    Goldman ID; Lichtenstein NS; Oliverio VT
    J Biol Chem; 1968 Oct; 243(19):5007-17. PubMed ID: 5303004
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells.
    Matherly LH; Muench SP
    Biochem Pharmacol; 1990 Jun; 39(12):2005-14. PubMed ID: 2141258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate coenzyme and antifolate transport proteins in normal and neoplastic cells.
    Freisheim JH; Price EM; Ratnam M
    Adv Enzyme Regul; 1989; 29():13-26. PubMed ID: 2561247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of dihydrofolate reductase, methotrexate transport, and growth of methotrexate-sensitive and -resistant L1210 leukemia cells in vitro by 5-substituted 2,4-diaminoquinazolines.
    Susten SS; Hynes JB; Kumar A; Freisheim JH
    Biochem Pharmacol; 1985 Jun; 34(12):2163-7. PubMed ID: 4004934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of folate compounds, pterins and adenine in L1210 mouse leukemia cells.
    Huennekens FM; Suresh MR; Vitols KS; Henderson GB
    Adv Enzyme Regul; 1982; 20():389-408. PubMed ID: 7113803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
    Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
    Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate analogues. 30. Dihydrofolate reductase inhibition and in vitro tumor cell growth inhibition by N epsilon-(haloacetyl)-L-lysine and N delta-(haloacetyl)-L-ornithine analogues and an acivicin analogue of methotrexate.
    Rosowsky A; Solan VC; Forsch RA; Delcamp TJ; Baccanari DP; Freisheim JH
    J Med Chem; 1987 Aug; 30(8):1463-9. PubMed ID: 3112397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualization of folate transport proteins by covalent labeling with fluorescein methotrexate.
    Fan J; Pope LE; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1990; 30():3-12. PubMed ID: 2119551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
    Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
    Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational predictions of binding affinities to dihydrofolate reductase: synthesis and biological evaluation of methotrexate analogues.
    Graffner-Nordberg M; Marelius J; Ohlsson S; Persson A; Swedberg G; Andersson P; Andersson SE; Aqvist J; Hallberg A
    J Med Chem; 2000 Oct; 43(21):3852-61. PubMed ID: 11052790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
    Henderson GB; Tsuji JM
    Biochim Biophys Acta; 1990 Jan; 1051(1):60-70. PubMed ID: 2297542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
    Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
    J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
    Makulu DR; Fölsch E
    J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
    Sierra EE; Brigle KE; Spinella MJ; Goldman ID
    Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.